ArgusEye introduces AugaOne to speed up downstream bioprocess growth

ArgusEye, a supplier of revolutionary sensor options for real-time monitoring of organic techniques, right now introduced the introduction of the AugaOne™ sensor system. AugaOne is the primary product within the Firm’s sensor system platform, Auga™, and is tailor-made to speed up downstream monoclonal antibody (mAb) course of growth by offering particular real-time and automatic in-line knowledge with excessive sensitivity, with out requiring pattern pretreatment.

Using a nanoplasmonic sensing expertise platform, AugaOne provides particular real-time monitoring of vital high quality attributes and course of parameters to find out the optimum course of. Tailored for downstream processing, AugaOne facilitates functions resembling in-line detection of product breakthrough, in addition to the automated management of a multi-column chromatography arrange. Its extremely versatile, modular design permits the system to be simply and shortly built-in into current gear, rising course of effectivity and intensifying course of growth.

Primarily developed to help biopharmaceutical scientists within the detection and quantification of mAbs, AugaOne can deal with complicated samples resembling cell tradition and plasma, delivering strong, correct knowledge unbiased of matrix results, cells, and temperatures, with the plan to help course of growth of different biomolecules sooner or later. Moreover, its in-line monitoring capabilities tremendously scale back the necessity for time-consuming, manually carried out off-line evaluation, considerably decreasing manufacturing lead instances.

Biopharmaceutical growth depends closely on time-consuming and labor-intensive off-line evaluation for high quality management, with restricted merchandise accessible for particular in-line or in-line monitoring. Our Auga platform goals to remodel the bioprocessing workflow, enabling speedy, correct knowledge technology in real-time. Via the introduction of our new AugaOne sensor, we’re accelerating mAb course of growth workflows, taking us a step additional in our goal to help the speedy, steady and cost-effective manufacturing of biologics to convey lifesaving therapies to the market.

Erik Martinsson, CEO and Co-Founder, ArgusEye